Filing Details
- Accession Number:
- 0001415889-24-025781
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-10-30 18:12:25
- Reporting Period:
- 2024-10-28
- Accepted Time:
- 2024-10-30 18:12:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1984086 | Septerna Inc. | SEPN | () | DE |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1315082 | Ra Capital Healthcare Fund Lp | 200 Berkeley Street, 18Th Floor Boston MA 02116 | Yes | No | Yes | No | |
1346824 | Ra Capital Management, L.p. | 200 Berkeley Street, 18Th Floor Boston MA 02116 | No | No | No | No | |
1384859 | Peter Kolchinsky | C/O Ra Capital Management, L.p. 200 Berkeley Street, 18Th Floor Boston MA 02116 | Yes | No | Yes | No | |
1619841 | M. Rajeev Shah | C/O Ra Capital Management, L.p. 200 Berkeley Street, 18Th Floor Boston MA 02116 | Yes | No | Yes | No | |
1883840 | Ra Capital Nexus Fund Iii, L.p. | 200 Berkeley Street, 18Th Floor Boston MA 02116 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-10-28 | 1,695,515 | $0.00 | 1,695,515 | No | 4 | C | Indirect | See footnotes |
Common Stock | Acquisiton | 2024-10-28 | 1,130,343 | $0.00 | 1,130,343 | No | 4 | C | Indirect | See footnotes |
Common Stock | Acquisiton | 2024-10-28 | 3,828,400 | $18.00 | 5,523,915 | No | 4 | P | Indirect | See footnotes |
Common Stock | Acquisiton | 2024-10-28 | 341,600 | $18.00 | 1,471,943 | No | 4 | P | Indirect | See footnotes |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | See footnotes |
No | 4 | C | Indirect | See footnotes |
No | 4 | P | Indirect | See footnotes |
No | 4 | P | Indirect | See footnotes |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series B Preferred Stock | Disposition | 2024-10-28 | 14,598,896 | $0.00 | 1,695,515 | $0.00 |
Common Stock | Series B Preferred Stock | Disposition | 2024-10-28 | 9,732,596 | $0.00 | 1,130,343 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Footnotes
- Each share of Series B Preferred Stock (the "Preferred Stock") converted into shares of Common Stock of the Issuer on a one-for-8.6103 basis without payment of further consideration. Upon the closing of the Issuer's initial public offering (the "IPO"), the Preferred Stock was converted into the number of shares of Common Stock of the Issuer shown in column 7 of Table II. The Preferred Stock had no expiration date.
- RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund") and RA Capital Nexus Fund III, L.P. (the "Nexus Fund III"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, the Nexus Fund III, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein.
- Held directly by the Fund.
- Held directly by the Nexus Fund III.